PopulationsHumans

Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes

Nature Communications

The paper

Kuang‐Ming Liao, Jheng‐Yan Wu, Chih‐Cheng Lai

Min-Hwei College of Health Care Management · National Sun Yat-sen University

Nature Communications · 22 Aug 2026

doi.org/10.1038/s41467-026-77068-0 PubMed 42768061

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Drug Design, Development and Therapy · 5 Oct 2026
GLP-1 drugs added to SGLT2 inhibitors linked to lower kidney risk
Diabetes, Obesity & Metabolism · 4 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Diabetes, Obesity & Metabolism · 8 Oct 2026